 Michael Shirts
Concepts (164)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Molecular Dynamics Simulation | 21 | 2026 | 260 | 6.590 |
Why?
| | Thermodynamics | 29 | 2023 | 426 | 3.690 |
Why?
| | Muramidase | 4 | 2020 | 67 | 1.550 |
Why?
| | Proteins | 14 | 2024 | 1022 | 1.520 |
Why?
| | Solvents | 10 | 2020 | 113 | 1.170 |
Why?
| | Intrinsically Disordered Proteins | 3 | 2025 | 43 | 1.050 |
Why?
| | Models, Molecular | 11 | 2025 | 1619 | 0.960 |
Why?
| | Protein Folding | 5 | 2024 | 279 | 0.900 |
Why?
| | Ligands | 11 | 2024 | 674 | 0.800 |
Why?
| | Computer Simulation | 13 | 2022 | 1026 | 0.750 |
Why?
| | Terpenes | 1 | 2022 | 25 | 0.750 |
Why?
| | Bayes Theorem | 2 | 2022 | 433 | 0.750 |
Why?
| | Water | 5 | 2016 | 469 | 0.750 |
Why?
| | Liquid Crystals | 1 | 2022 | 30 | 0.740 |
Why?
| | Nucleic Acids | 1 | 2022 | 72 | 0.700 |
Why?
| | Protein Binding | 15 | 2024 | 2276 | 0.660 |
Why?
| | Polymers | 1 | 2024 | 499 | 0.610 |
Why?
| | Tumor Suppressor Protein p53 | 2 | 2012 | 531 | 0.550 |
Why?
| | Monte Carlo Method | 5 | 2022 | 155 | 0.530 |
Why?
| | Models, Chemical | 8 | 2016 | 269 | 0.520 |
Why?
| | Amides | 2 | 2021 | 101 | 0.520 |
Why?
| | Bacteriophage T4 | 2 | 2013 | 18 | 0.500 |
Why?
| | Drug Design | 5 | 2016 | 173 | 0.490 |
Why?
| | Imidazoles | 3 | 2020 | 254 | 0.490 |
Why?
| | Selenium Compounds | 1 | 2016 | 18 | 0.480 |
Why?
| | Cadmium Compounds | 1 | 2016 | 31 | 0.470 |
Why?
| | Quantum Dots | 1 | 2016 | 39 | 0.470 |
Why?
| | Nanotubes, Carbon | 1 | 2016 | 48 | 0.460 |
Why?
| | Bridged-Ring Compounds | 2 | 2020 | 31 | 0.450 |
Why?
| | T-Lymphocytes | 1 | 2023 | 1982 | 0.440 |
Why?
| | Dextrans | 1 | 2015 | 86 | 0.430 |
Why?
| | Ethers, Cyclic | 1 | 2014 | 11 | 0.420 |
Why?
| | Resorcinols | 1 | 2014 | 5 | 0.420 |
Why?
| | Carboxylic Acids | 1 | 2014 | 34 | 0.410 |
Why?
| | Catalytic Domain | 3 | 2023 | 234 | 0.410 |
Why?
| | HIV Reverse Transcriptase | 1 | 2013 | 31 | 0.400 |
Why?
| | Molecular Conformation | 5 | 2024 | 148 | 0.390 |
Why?
| | Reverse Transcriptase Inhibitors | 1 | 2013 | 87 | 0.390 |
Why?
| | Biosensing Techniques | 2 | 2026 | 139 | 0.390 |
Why?
| | Protein Structure, Secondary | 4 | 2023 | 369 | 0.380 |
Why?
| | Binding Sites | 6 | 2016 | 1331 | 0.370 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 1 | 2012 | 66 | 0.360 |
Why?
| | Quantum Theory | 4 | 2026 | 93 | 0.350 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2012 | 194 | 0.340 |
Why?
| | Insulin | 1 | 2022 | 2507 | 0.330 |
Why?
| | Peptide Fragments | 3 | 2012 | 699 | 0.330 |
Why?
| | Enzyme Inhibitors | 2 | 2023 | 826 | 0.300 |
Why?
| | Amino Acids | 2 | 2021 | 522 | 0.290 |
Why?
| | Tacrolimus Binding Protein 1A | 2 | 2007 | 10 | 0.280 |
Why?
| | Protein Conformation | 6 | 2015 | 946 | 0.280 |
Why?
| | RNA-Binding Proteins | 1 | 2012 | 464 | 0.280 |
Why?
| | Arabidopsis Proteins | 2 | 2026 | 76 | 0.270 |
Why?
| | Macrocyclic Compounds | 2 | 2020 | 15 | 0.260 |
Why?
| | Allosteric Site | 2 | 2023 | 18 | 0.250 |
Why?
| | Data Interpretation, Statistical | 1 | 2008 | 372 | 0.250 |
Why?
| | Software | 3 | 2018 | 692 | 0.240 |
Why?
| | Tacrolimus | 1 | 2007 | 196 | 0.240 |
Why?
| | Phase Transition | 1 | 2025 | 26 | 0.230 |
Why?
| | 3-Oxoacyl-(Acyl-Carrier-Protein) Reductase | 1 | 2025 | 2 | 0.230 |
Why?
| | Protein Domains | 2 | 2025 | 313 | 0.230 |
Why?
| | Peptides | 3 | 2023 | 998 | 0.230 |
Why?
| | Energy Transfer | 1 | 2005 | 49 | 0.220 |
Why?
| | Mammals | 2 | 2023 | 293 | 0.220 |
Why?
| | Pseudomonas putida | 1 | 2025 | 42 | 0.210 |
Why?
| | Entropy | 4 | 2023 | 45 | 0.210 |
Why?
| | Benchmarking | 2 | 2026 | 188 | 0.210 |
Why?
| | Adsorption | 2 | 2015 | 157 | 0.210 |
Why?
| | Drug Discovery | 3 | 2016 | 155 | 0.210 |
Why?
| | Molecular Structure | 4 | 2021 | 501 | 0.210 |
Why?
| | Bias | 1 | 2005 | 202 | 0.210 |
Why?
| | Hydrogen Bonding | 2 | 2022 | 169 | 0.200 |
Why?
| | Biopolymers | 1 | 2024 | 35 | 0.200 |
Why?
| | Mutation | 2 | 2023 | 4099 | 0.200 |
Why?
| | Organelles | 1 | 2024 | 57 | 0.200 |
Why?
| | Protein Tyrosine Phosphatases | 1 | 2023 | 168 | 0.180 |
Why?
| | Petroselinum | 1 | 2021 | 2 | 0.180 |
Why?
| | Dimerization | 1 | 2022 | 194 | 0.180 |
Why?
| | Models, Theoretical | 3 | 2020 | 582 | 0.180 |
Why?
| | Polysaccharides | 1 | 2022 | 87 | 0.180 |
Why?
| | Cellulase | 2 | 2012 | 32 | 0.170 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2020 | 381 | 0.150 |
Why?
| | Uncertainty | 3 | 2016 | 145 | 0.150 |
Why?
| | Methane | 2 | 2013 | 51 | 0.150 |
Why?
| | Reproducibility of Results | 3 | 2018 | 3415 | 0.140 |
Why?
| | Analgesics, Opioid | 1 | 2026 | 1143 | 0.130 |
Why?
| | Algorithms | 4 | 2013 | 1839 | 0.130 |
Why?
| | Cyclohexanes | 1 | 2016 | 23 | 0.120 |
Why?
| | Electrons | 1 | 2016 | 88 | 0.120 |
Why?
| | Biophysics | 2 | 2006 | 74 | 0.110 |
Why?
| | Chromatography, Ion Exchange | 1 | 2015 | 57 | 0.110 |
Why?
| | Static Electricity | 1 | 2015 | 113 | 0.110 |
Why?
| | Porosity | 1 | 2015 | 96 | 0.110 |
Why?
| | Diffusion | 1 | 2015 | 122 | 0.110 |
Why?
| | Motion | 1 | 2015 | 100 | 0.110 |
Why?
| | Pharmaceutical Preparations | 1 | 2016 | 170 | 0.110 |
Why?
| | Glucosidases | 1 | 2013 | 3 | 0.100 |
Why?
| | Rilpivirine | 1 | 2013 | 10 | 0.100 |
Why?
| | Nevirapine | 1 | 2013 | 18 | 0.100 |
Why?
| | Substrate Specificity | 3 | 2025 | 392 | 0.100 |
Why?
| | Oligosaccharides | 1 | 2013 | 60 | 0.100 |
Why?
| | Periodicity | 1 | 2013 | 58 | 0.100 |
Why?
| | Kinetics | 2 | 2015 | 1629 | 0.100 |
Why?
| | Principal Component Analysis | 1 | 2013 | 198 | 0.100 |
Why?
| | Biophysical Phenomena | 1 | 2013 | 68 | 0.090 |
Why?
| | Nitriles | 1 | 2013 | 205 | 0.090 |
Why?
| | Molecular Docking Simulation | 1 | 2012 | 124 | 0.090 |
Why?
| | Toluene | 1 | 2012 | 12 | 0.090 |
Why?
| | Deuterium Exchange Measurement | 1 | 2011 | 27 | 0.090 |
Why?
| | Complementarity Determining Regions | 1 | 2011 | 53 | 0.090 |
Why?
| | Immunoglobulin Fab Fragments | 1 | 2011 | 56 | 0.090 |
Why?
| | Trichoderma | 1 | 2011 | 28 | 0.080 |
Why?
| | Carbohydrates | 1 | 2011 | 66 | 0.080 |
Why?
| | Fungal Proteins | 1 | 2011 | 145 | 0.080 |
Why?
| | Alanine | 1 | 2011 | 171 | 0.080 |
Why?
| | Piperazines | 1 | 2012 | 381 | 0.080 |
Why?
| | Pyrimidines | 1 | 2013 | 533 | 0.080 |
Why?
| | Chemistry, Physical | 2 | 2006 | 39 | 0.070 |
Why?
| | Ethanol | 1 | 2013 | 627 | 0.070 |
Why?
| | Laboratories | 1 | 2008 | 109 | 0.070 |
Why?
| | Time Factors | 4 | 2013 | 7183 | 0.060 |
Why?
| | Computational Biology | 1 | 2011 | 681 | 0.060 |
Why?
| | Acyl Carrier Protein | 1 | 2025 | 9 | 0.060 |
Why?
| | Tacrolimus Binding Proteins | 1 | 2005 | 26 | 0.060 |
Why?
| | Antibodies, Monoclonal, Humanized | 1 | 2011 | 988 | 0.060 |
Why?
| | Benzoxazines | 1 | 2024 | 31 | 0.050 |
Why?
| | Naphthalenes | 1 | 2024 | 56 | 0.050 |
Why?
| | Crystallography, X-Ray | 1 | 2025 | 493 | 0.050 |
Why?
| | Morpholines | 1 | 2024 | 129 | 0.050 |
Why?
| | Humans | 8 | 2022 | 144957 | 0.050 |
Why?
| | Protein Engineering | 1 | 2024 | 122 | 0.050 |
Why?
| | Solubility | 2 | 2016 | 242 | 0.040 |
Why?
| | DNA | 1 | 2008 | 1464 | 0.040 |
Why?
| | Circular Dichroism | 1 | 2021 | 150 | 0.040 |
Why?
| | Physical Phenomena | 1 | 2020 | 13 | 0.040 |
Why?
| | Temperature | 2 | 2011 | 679 | 0.030 |
Why?
| | Amino Acid Sequence | 3 | 2011 | 2157 | 0.030 |
Why?
| | Molecular Sequence Data | 3 | 2011 | 2931 | 0.030 |
Why?
| | Ecosystem | 1 | 2021 | 589 | 0.030 |
Why?
| | Small Molecule Libraries | 1 | 2016 | 111 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2016 | 570 | 0.030 |
Why?
| | Guidelines as Topic | 1 | 2015 | 268 | 0.020 |
Why?
| | Dextrins | 1 | 2012 | 3 | 0.020 |
Why?
| | Cellobiose | 1 | 2012 | 6 | 0.020 |
Why?
| | Glycoside Hydrolases | 1 | 2012 | 39 | 0.020 |
Why?
| | Cellulose | 1 | 2012 | 58 | 0.020 |
Why?
| | Chromatography, Gel | 1 | 2011 | 131 | 0.020 |
Why?
| | Freezing | 1 | 2011 | 86 | 0.020 |
Why?
| | Animals | 2 | 2023 | 38109 | 0.020 |
Why?
| | Protein Stability | 1 | 2011 | 178 | 0.020 |
Why?
| | Bevacizumab | 1 | 2011 | 167 | 0.020 |
Why?
| | Protein Multimerization | 1 | 2011 | 214 | 0.020 |
Why?
| | Mass Spectrometry | 1 | 2011 | 750 | 0.020 |
Why?
| | Probability | 1 | 2006 | 312 | 0.010 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2005 | 192 | 0.010 |
Why?
| | Cluster Analysis | 1 | 2006 | 521 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2011 | 1524 | 0.010 |
Why?
| | Viscosity | 1 | 2003 | 90 | 0.010 |
Why?
| | Neurofilament Proteins | 1 | 2002 | 80 | 0.010 |
Why?
| | Models, Statistical | 1 | 2006 | 682 | 0.010 |
Why?
| | Microfilament Proteins | 1 | 2003 | 136 | 0.010 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2005 | 2032 | 0.010 |
Why?
| | Nuclear Magnetic Resonance, Biomolecular | 1 | 2002 | 346 | 0.010 |
Why?
| | Nerve Tissue Proteins | 1 | 2003 | 592 | 0.010 |
Why?
| | Carrier Proteins | 1 | 2003 | 737 | 0.010 |
Why?
|
|
Shirts's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|